CIRM awards $2.4 million training grant to the Gladstone Institutes

September 12, 2005

The California Institute for Regenerative Medicine (CIRM) has awarded the J. David Gladstone Institutes a $2.4 million grant to create a CIRM Scholars Training Program focusing on stem cell research. The training grant, part of CIRM's first-ever round of awards, enables Gladstone to develop and implement an intensive stem cell-specific curriculum for ten postdoctoral fellows over a three-year period.

Gladstone Institutes President Robert W. Mahley, MD, PhD, a professor of medicine and pathology at the University of California, San Francisco (UCSF), will serve as the director of the CIRM Scholars Training Program. Gladstone Institute of Cardiovascular Disease Associate Investigator Bruce Conklin, MD, a UCSF associate professor of medicine and cellular and molecular pharmacology, will serve as associate director.

In cooperation with a wide spectrum of universities and colleges throughout Northern California, Gladstone will develop a core curriculum of required and elective courses spanning a variety of stem cell research disciplines. Participating institutions include University of California campuses in San Francisco, Berkeley, Davis, and Santa Cruz, as well as San Francisco State University and the Children's Hospital of Oakland Research Institute.

The Gladstone Institutes, an independent, nonprofit medical research institution affiliated with the University of California, San Francisco (UCSF), conducts basic research into the causes of three of the most significant medical problems of modern times: cardiovascular disease, HIV/AIDS, and neurodegenerative disorders. Each of these research areas involves promising targets for regenerative medicine: Over the 26 years of its history, Gladstone has trained more than 300 postdoctoral scholars. In a national survey by The Scientist earlier this year, Gladstone was rated as the 12th top institutional work environment for U.S. life sciences postdoctoral fellows in 2005 (123 institutions were ranked).

The CIRM is a state agency that was created by the California Stem Cell Research and Cures Act, a ballot measure passed by 59 percent of California voters in November 2004. Over the next 10 years, the CIRM will disburse almost $3 billion in state bond funds to investigators at California universities and research institutions for stem cell research. Research funded by the CIRM will focus on understanding the fundamental mechanisms related to stem cells and how they apply to the development of disease. All proposals are peer-reviewed to focus on the most promising science.

For further details about the Gladstone Institutes, visit

Gladstone Institutes

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to